BIOMAT Database Logo BIOMAT Database Logo

Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats. 2000

Y Maki, and T Inoue, and T Izumi, and I Muraki, and K Ito, and Y Kitaichi, and X Li, and T Koyama
Department of Psychiatry, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, 060-8638, Sapporo, Japan.

The present study examined the acute anxiolytic effects of monoamine oxidase inhibitors on freezing behavior, a putative index of anxiety induced by conditioned fear stress. The selective serotonin 1A receptor agonist tandospirone (0.1-10 mg/kg) inhibited freezing dose dependently. The irreversible, non-selective monoamine oxidase inhibitors tranylcypromine (3 and 15 mg/kg) and phenelzine (30 and 80 mg/kg) reduced freezing significantly. Clorgyline (10 mg/kg, irreversible selective monoamine oxidase A inhibitor), N-(2-aminoethyl)-5-(m-fluorophenyl)-4-thiazole carboxamide (Ro 41-1049) (30 mg/kg, reversible selective monoamine oxidase A inhibitor), selegiline (3 mg/kg, irreversible selective monoamine oxidase B inhibitor) and lazabemide (10 mg/kg, reversible selective monoamine oxidase B inhibitor) had no effect on freezing behavior. However, combined administration of clorgyline (10 mg/kg) and selegiline (3 mg/kg) reduced freezing significantly, as well as combined administration of clorgyline (10 mg/kg) and lazabemide (10 mg/kg), Ro 41-1049 (30 mg/kg) and selegiline (3 mg/kg), or Ro 41-1049 (30 mg/kg) and lazabemide (10 mg/kg). These effects of monoamine oxidase inhibitors on freezing were not due to non-specific motor effects. These results suggest that acute inhibition of both monoamine oxidase A and B reduced anxiety or fear, while inhibition of monoamine oxidase A or B alone failed to reduce anxiety or fear.

UI MeSH Term Description Entries
D008297 Male Males
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005239 Fear The affective response to an actual current external danger which subsides with the elimination of the threatening condition. Threat Cues,Threat Sensitivity,Cue, Threat,Fears,Sensitivity, Threat,Threat Cue,Threat Sensitivities
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D014151 Anti-Anxiety Agents Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. Anti-Anxiety Agent,Anti-Anxiety Drug,Anxiolytic,Anxiolytic Agent,Anxiolytic Agents,Tranquilizing Agents, Minor,Anti-Anxiety Drugs,Anti-Anxiety Effect,Anti-Anxiety Effects,Antianxiety Effect,Antianxiety Effects,Anxiolytic Effect,Anxiolytic Effects,Anxiolytics,Tranquillizing Agents, Minor,Agent, Anti-Anxiety,Agent, Anxiolytic,Agents, Anti-Anxiety,Agents, Anxiolytic,Agents, Minor Tranquilizing,Agents, Minor Tranquillizing,Anti Anxiety Agent,Anti Anxiety Agents,Anti Anxiety Drug,Anti Anxiety Drugs,Anti Anxiety Effect,Anti Anxiety Effects,Drug, Anti-Anxiety,Drugs, Anti-Anxiety,Effect, Anti-Anxiety,Effect, Antianxiety,Effect, Anxiolytic,Effects, Anti-Anxiety,Effects, Antianxiety,Effects, Anxiolytic,Minor Tranquilizing Agents,Minor Tranquillizing Agents
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D017551 Microdialysis A technique for measuring extracellular concentrations of substances in tissues, usually in vivo, by means of a small probe equipped with a semipermeable membrane. Substances may also be introduced into the extracellular space through the membrane.

Related Publications

Y Maki, and T Inoue, and T Izumi, and I Muraki, and K Ito, and Y Kitaichi, and X Li, and T Koyama
Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats.
January 1996, Psychopharmacology,
Y Maki, and T Inoue, and T Izumi, and I Muraki, and K Ito, and Y Kitaichi, and X Li, and T Koyama
Kamishoyosan reduces conditioned fear-induced freezing behavior in socially isolated ovariectomized rats.
August 2016, Journal of pharmacological sciences,
Y Maki, and T Inoue, and T Izumi, and I Muraki, and K Ito, and Y Kitaichi, and X Li, and T Koyama
Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats.
July 1999, European journal of pharmacology,
Y Maki, and T Inoue, and T Izumi, and I Muraki, and K Ito, and Y Kitaichi, and X Li, and T Koyama
l-Sulpiride, at a low, non-neuroleptic dose, prevents conditioned fear stress-induced freezing behavior in rats.
March 1999, Psychopharmacology,
Y Maki, and T Inoue, and T Izumi, and I Muraki, and K Ito, and Y Kitaichi, and X Li, and T Koyama
Effect of repeated methamphetamine pretreatment on freezing behavior induced by conditioned fear stress.
August 1996, Pharmacology, biochemistry, and behavior,
Y Maki, and T Inoue, and T Izumi, and I Muraki, and K Ito, and Y Kitaichi, and X Li, and T Koyama
Rosmarinic acid and caffeic acid reduce the defensive freezing behavior of mice exposed to conditioned fear stress.
November 2002, Psychopharmacology,
Y Maki, and T Inoue, and T Izumi, and I Muraki, and K Ito, and Y Kitaichi, and X Li, and T Koyama
Conditioned taste aversion induced in rats by intracerebral or systemic administration of monoamine oxidase inhibitors.
January 1987, Psychopharmacology,
Y Maki, and T Inoue, and T Izumi, and I Muraki, and K Ito, and Y Kitaichi, and X Li, and T Koyama
The potentiation of serotonergic activity reduces conditioned fear-induced freezing behavior.
June 1993, The Japanese journal of psychiatry and neurology,
Y Maki, and T Inoue, and T Izumi, and I Muraki, and K Ito, and Y Kitaichi, and X Li, and T Koyama
Effects of monoamine oxidase inhibitors on phencylidine induced stereotyped behavior and brain levels in rats.
January 1979, Proceedings of the Western Pharmacology Society,
Y Maki, and T Inoue, and T Izumi, and I Muraki, and K Ito, and Y Kitaichi, and X Li, and T Koyama
Haloperidol and methylphenidate alter motor behavior and responses to conditioned fear of Carioca Low-conditioned Freezing rats.
December 2021, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!